FGF2 and cancer: Here, we expand on the FGF-based targeted anti-cancer cytotoxic drug approach by applying the FGF2 dimer as a targeting molecule and through conjugation of two cytotoxic agents with independent modes of action: the antimitotic agent MMAE and the RNA polymerase II and III inhibitor α-amanitin (αAMTN) using two enzymatic ligations.